Peds Hematology Flashcards
What is the actual definition of anemia?
A reduction in RBC mass or blood hemoglobin concentration 2 standard deviations below normal for age and sex
Hgb concentration < 11 g/dL for both male and female children aged 6 months to < 5 years
What causes Normocytic, normochromic anemia?
Anemia of chronic disease
What causes microcytic, hypochromic anemia?
Iron deficiency, thalassemia, lead intoxication
What causes macrocytic anemia?
Vitamin B12 and folate deficiency
SSx of anemia
Acute:
• Lethargy, tachycardia, pallor
• Infants - irritability and poor oral intake
Chronic:
• May present with few or no symptoms at all
Other findings: • Jaundice • Gallstone disease • Petechiae •Purpura • Ecchymosis •Bleeding
Inherited bone marrow failure syndrome
Fanconi Anemia
Autosomal recessive —> defective DNA repair
Majority (75-90%) develop bone marrow failure in the first 10 years of life (usually soon - 1st 5 years)
Clinical manifestations of Fanconi Anemia
Progressive pancytopenia
Several congenital malformations
• Abnormal pigmentation of skin
• Short stature
• Skeletal malformations
Increased incidence of malignancies
Condition often initially misdiagnosed as ITP
Fanconi Anemia
Misdiagnosed because it begins with Thrombocytopenia or leukopenia before anemia begins
Eventually the anemia —> severe aplastic anemia (low or no production of new cells)
Treatment for Fanconi Anemia
Supportive treatment
• Anemia (maybe a transfusion?)
• Thrombocytopenia (platelet transfusion?)
• Neutropenia (meds to stimulate WBC production)
Once all cell lines are affected, requires Hematopoietic Stem Cell Transplant (HSCT)
What is the prognosis for patients with Fanconi Anemia
Many succumb to bleeding, infection, or malignancy in adolescence or early adulthood
Patients are at high risk of developing Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
Peripheral pancytopenia with a hypocellular bone marrow
Acquired Aplastic Anemia
~50% of the cases in childhood are idiopathic
Other causes: medications, toxic exposure (insecticides), and viruses (Mono, Hepatitis, HIV)
SSx of Acquired Aplastic Anemia
Weakness, fatigue, pallor (duh, it’s anemia)
Frequent or severe infections (duh, leukocytopenia)
Purpura, petechiae, and bleeding (duh, thrombocytopenia)
Lab findings with acquired aplastic anemia
Anemia, usually normocytic b/c it’s chronic
Low WBC with marked neutropenia
Thrombocytopenia
Low reticulocyte count b/c bone marrow is failing so few new RBCs are being made
Complications of acquired aplastic anemia
Overwhelming infection and severe hemorrhage are leading causes of death
Treatment for acquired aplastic anemia
Supportive care
Referral to heme
Stop offending agent if there is one
Abx for infection
RBC transfusions for severe anemia
Platelet transfusions (sparingly)
Immunosuppressant agents
Hematopoietic Stem Cell Transplant (HSCT)
The most common nutritional deficiency in children
Iron deficiency
Prevalence is greatest among toddlers aged 1-2 and females of childbearing age
Prevalence higher in African-American & Hispanic children and those living in poverty (low socio-economic status)
SSx of iron deficiency
Varies with severity Asymptomatic Pallor Fatigue, irritability Delayed motor development Hx of Pica
When should screening for iron deficiency be conducted?
At 12 months, per AAP guidelines
Determine hemoglobin concentration
Assessment of risk factors
Risk factors for iron deficiency anemia
Low socioeconomic status
Prematurity/low-birth weight
Lead exposure
Exclusive breast-feeding beyond 4 months of age w/o iron supplementation
Weaning to whole milk or foods that do not contain iron
Feeding problems, poor growth, inadequate nutrition
Lab findings for iron deficiency
Microcytic, hypochromic anemia
Hemoglobin <11 g/dL w/ MCV < 80 and increased RDW
Ferritin < 12 mcg/L (iron stores)
AAP guidelines for the treatment of iron deficiency anemia
Hemoglobin of 10-11 mg/dL at 12-month screening visit
• Closely monitor or empirically treat
• Recheck hemoglobin in one month
ID/IDA
• Iron 6 mg/kg/d, 3 divided daily doses
What are the main causes of Vitamin B12 deficiency
Intestinal malabsorption (Crohn, Celiac, IBD)
Dietary insufficiency - esp vegans, as B12 is only in animal products
Causes of folic acid deficiency
Increased folate requirements (rapid growth, chronic hemolytic anemia)
Malabsorption syndromes
Inadequate dietary intake (rare)
Medications
SSx of megaloblastic anemia
Pallor
GLOSSITIS
Older children with B12 can have paresthesias, weakness, or unsteady gait, decreased vibratory sensation and proprioception on neuro exam
***Neurologic SSx ONLY occur with B-12 and not folate deficiency
Lab findings in megaloblastic anemia
Elevated MCV and MCH
Low levels of either folic acid and/or vitamin B12
Neutrophils are large and have hypersegmented nuclei
Macro-ovalocytes (large, oval RBCs)
***Elevated methylmalonic acid seen with B-12 deficiency ONLY
***Elevated homocysteine seen with B-12 AND folate deficiency
Treatment for megaloblastic anemia
Vitamin B12 and/or folic acid supplementation
Treatment with folate will fix the anemia picture in B-12 deficiency BUT you MUST treat vitamin B-12 deficiency to avoid permanent neurological deficits
Red cell membrane defect leading to hemolytic anemia —> jaundice, splenomegaly, gallstones
Hereditary Spherocytosis (HS)
Increased osmotic fragility —> spherocytes
Tx: supportive care +/- RBC transfusion, may need a splenectomy (make sure they have pneumococcal vaccine first
Severity of Thalassemia is related to…
The number of gene deletions
Can affect either Alpha or Beta chains of hemoglobin
Microcytic hypochromic anemia of variable severity, due to genetic deletions of alpha or beta chain genes
Thalassemia
Dx via hemoglobin electrophoresis
Supportive +/- RBC transfusion
• Iron monitoring and chelation
• Splenectomy may help
• HSCT if severe beta-thalassemia
HbS electrophoresis is used to diagnose…
Sickle Cell Disease
Homozygous HbSS —> disease
Vaso-occlusion —> pain (most common Sx)
Chronic hemolysis
Splenomegaly
Splenic infarcts —> functional asplenia
Increased risk of bacterial sepsis
May see growth failure and delayed puberty
Treatment options for Sickle Cell disease
Avoiding precipitating factors Supportive care Hydroxyurea Treatment for painful vaso-occlusive episodes HSCT